Androgen Receptor Pathway Inhibitors (ARPIs): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Phase 2 1
Phase 3 1
Not applicable 1
Conditions being studied
Recruiting trials involving Androgen Receptor Pathway Inhibitors (ARPIs)
- PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
- Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Common questions
How many recruiting trials involve Androgen Receptor Pathway Inhibitors (ARPIs)?
2 recruiting trials across 7 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.